Mana Shojpaour

Dr. Mana Shojpaour


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2021 in Neurological Research
Verified
Journal Article
Closed access
FFFardin Faraji
Fardin Faraji
MSMana Shojpaour
Mana Shojpaour
IFIman Farahani
Iman Farahani
AGAli Ganji
Ali Ganji
GMGhasem Mosayebi
Ghasem Mosayebi
Objectives: Migraine is a primary headache disorder with unknown pathophysiology. Recently, many studies have suggested the role of immune dysfunction in the pathophysiology of this disorder. In this study, we investigated the percentage of regulatory T cells (Treg cells) in different migraine categories. Methods: Peripheral blood samples of 40 newly diagnosed cases of migraine and 33 healthy individuals were collected for Treg cell analysis by flow cytometry. Results: The percentage of Treg cells in migraine patients with all subgroups including patients with or without auras and patients with chronic or episodic migraine was significantly lower than that of the control group. Also, a significant increase in the CD25 means fluorescence intensity (MFI) was observed in migraine without aura and chronic migraine groups, compared to the normal group. Conclusions: In this study, the number of Treg cells significantly decreased in new cases of migraine, which suggests that migraine is a result of an impairment in the immunological system or an autoimmune disease. Also, the insignificant difference in the number of Treg cells between the two categories of migraine suggests that there is no link between the reduced number of Treg cells and the emergence of aura symptoms or duration of the disease.

23 February 2023 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
FFFardin Faraji
Fardin Faraji
GMGhasem Mosayebi
Ghasem Mosayebi
MBMaryam Bahrami
Maryam Bahrami
MSMana Shojpaour
Mana Shojpaour
Background: Migraine is a neurovascular disorder; several studies have demonstrated the immune system plays a key role in migraine pathogenesis. The aim of this study was to investigate the association between FOXP3 gene polymorphism and susceptibility to migraine. Methods: In a case–control study, 55 whole blood samples of patients with migraine and 80 healthy samples were collected. After DNA extraction, genotyping of the rs5902434 (del/ATT) and rs3761548 (C/A) FOXP3 was performed using sequence-specific primers method (PCR-SSP). Results: The results of this study showed that there were statistically significant differences between patient and control group in genotype frequencies of rs3761548. In addition, the frequency of heterozygous genotype AC at rs3761548 in patients was found to be significantly higher than controls. We also found no significant differences between cases and controls were found in the allelic and genotype distribution of the rs5902434 (del/ATT) polymorphism. None of the rs5902434 (del/ATT) genotypes showed any significant association with the migraine. Conclusions: According to finding of our study, polymorphism rs3761548 in FOXP3 gene were associated with susceptibility to migraine. Further studies with larger sample sizes and different populations in other parts of the world are needed to investigate relationship between this polymorphism on migraine susceptibility.

24 August 2024 in Journal of Kerman University of Medical Sciences
Verified
Journal Article
Closed access
PDF file
FFFardin Faraji
Fardin Faraji
GMGhasem Mosayebi
Ghasem Mosayebi
ATAfsoon Talaie
Afsoon Talaie
FRFatemeh Rafiei
Fatemeh Rafiei
MRMobina Ranavbakhsh
Mobina Ranavbakhsh
HAHossein Ansari
Hossein Ansari
Background: Migraine is a complex neurological disorder. The precise etiology of migraine is not clear. Many studies have been conducted on the association of the immune system with migraine pathophysiology. Neurogenic inflammation, the main pathomechanism of migraine, is well described. This study evaluated the pattern of changes in interleukin (IL)-1β, IL-17A, total antioxidant capacity (TAC), and malondialdehyde (MDA) in migraine patients. Methods: In this case-control study, serum samples were taken from 31 migraine patients referred to the neurology clinics of medical centers associated with Arak University of Medical Sciences. The severity of the headache was assessed with standard questionnaires. Serum samples were also obtained from 30 normal individuals. The IL-1β and IL-17A levels were measured by a sensitive ELISA method. TAC was measured by the FRAP technique, and lipid peroxidation levels were evaluated by an MDA assay. Data were analyzed descriptively and analytically using SPSS 21 software. Results: The results showed that the mean level of IL-1β in the case group was significantly higher than the control group (P=0.01). The mean level of IL-17A was not significantly different in the two groups. The mean serum MDA level in the study group was significantly higher than in the controls (P=0.005). No statistical difference was observed in the mean serum level of TAC between the two groups. Conclusion: According to our results, the pathogenesis of migraine can be associated with immune system function, and inhibition of pro-inflammatory cytokine production may be effective in treating migraine patients.